• head_banner_01

Nā API peptide

  • Tirzepatide

    Tirzepatide

    ʻO Tirzepatide kahi mea hou agonist ʻelua o GIP a me GLP-1 receptors, i hoʻomohala ʻia no ka mālama ʻana i ka maʻi diabetes type 2 a me ka momona. Ma ke ʻano he "twincretin" papa mua, hoʻomaikaʻi ʻo Tirzepatide i ka huna ʻana o ka insulin, hoʻopau i ka hoʻokuʻu glucagon, a hoʻemi nui i ka ʻai a me ke kaumaha o ke kino. ʻO kā mākou Tirzepatide API hoʻomaʻemaʻe kiʻekiʻe ua hoʻohui ʻia me ka kemika, ʻaʻohe o nā mea haumia i loaʻa mai i ka host-cell, a hoʻokō i nā kūlana hoʻoponopono honua no ka maikaʻi, kūpaʻa, a me ka scalability.

  • Semaglutide

    Semaglutide

    ʻO Semaglutide kahi agonist receptor GLP-1 lōʻihi i hoʻohana ʻia no ka mālama ʻana i ka maʻi diabetes type 2 a me ka hoʻokele kaumaha mau. Hoʻokumu ʻia kā mākou Semaglutide API maʻemaʻe kiʻekiʻe ma o ka synthesis kemika, manuahi mai nā protein cell host a me nā koena DNA, e hōʻoiaʻiʻo ana i ka biosafety maikaʻi a me ka maikaʻi mau. Hoʻokō me nā alakaʻi FDA, hoʻokō kā mākou huahana i nā palena haumia ikaika a kākoʻo i ka hana nui.

  • Retatrutide

    Retatrutide

    ʻO Retaglutide kahi dipeptidyl peptidase-4 (DPP-4) inhibitor class hypoglycemic lāʻau lapaʻau hou e hiki ke pale i ka hōʻino ʻana o ka glucagon-like peptide-1 (GLP-1) a me ka glucose-dependent insulin-releasing polypeptide (GIP) e DPP-4 enzyme i loko o ka ʻōpū a me ke koko, e hoʻolōʻihi i kā lākou hana, me ka ʻole o ka hoʻoulu ʻana i ka insulin basalβ i ka pae. e hoʻemi ana i ka huna ʻana o ka glucagon e nā pūnaewele α pancreatic, a laila ʻoi aku ka maikaʻi o ka mālama ʻana i ke kō koko postprandial. Hana maikaʻi ʻo ia ma ke ʻano o ka hopena hypoglycemic, hoʻomanawanui, a me ka hoʻokō.

  • ʻO Liraglutide Anti-Diabetics no ka mālama ʻana i ke kō koko CAS NO.204656-20-2

    ʻO Liraglutide Anti-Diabetics no ka mālama ʻana i ke kō koko CAS NO.204656-20-2

    Mea hoʻoikaika kino:Liraglutide (analog o ke kanaka glucagon-like peptide-1 (GLP-1) i hana ʻia e ka hū ma o ka ʻenehana recombination genetic).

    Inoa Kimia:Arg34Lys26-(N-ε-(γ-Glu(N-α-hexadecanoyl)))-GLP-1[7-37]

    Nā mea ʻē aʻe:Disodium Hydrogen Phosphate Dihydrate, Propylene Glycol, Hydrochloric Acid a/a i ʻole Sodium Hydroxide (e like me nā mea hoʻoponopono pH wale nō), Phenol, a me ka wai no ka hoʻokomo ʻana.

  • Hoʻoponopono ʻo Leuprorelin Acetate i ka huna ʻana o nā Hormones Gonadal

    Hoʻoponopono ʻo Leuprorelin Acetate i ka huna ʻana o nā Hormones Gonadal

    Ka inoa: Leuprorelin

    Helu CAS: 53714-56-0

    Kumu molekala: C59H84N16O12

    Kaumaha molekula: 1209.4

    Helu EINECS: 633-395-9

    Ka hoʻololi kikoʻī: D25 -31.7° (c = 1 i ka 1% acetic acid)

    Māmā: 1.44±0.1 g/cm3 (Wanamua)

  • BPC-157

    BPC-157

    Hoʻohana ka BPC-157 API i ke kaʻina hana solid phase synthesis (SPPS):
    Maʻemaʻe kiʻekiʻe: ≥99% (ʻike HPLC)
    Ke koena haumia haʻahaʻa, ʻaʻohe endotoxin, ʻaʻohe haumia metala kaumaha
    Paʻa paʻa, hoʻihoʻi ikaika, kākoʻo i ka hoʻohana pae injection
    E kākoʻo i ka lako o ka pae gram a me kilokani e hoʻokō i nā pono o nā pae like ʻole mai R&D a hiki i ka ʻoihana.

  • CJC-1295

    CJC-1295

    Hana ʻia ʻo CJC-1295 API me ka hoʻohana ʻana i ka ʻenehana solid phase peptide synthesis (SPPS) a hoʻomaʻemaʻe ʻia me ka hoʻohana ʻana i ka HPLC e hoʻokō i ka maʻemaʻe kiʻekiʻe a me ka hui pū ʻana.
    Nā hiʻohiʻona huahana:

    Maʻemaʻe ≥ 99%

    ʻO nā mea hoʻoheheʻe koena haʻahaʻa a me nā metala kaumaha

    Endotoxin-noa, non-immunogenic synthesis ala

    Nā nui hiki ke hoʻopilikino ʻia: mg i kg

  • NAD+

    NAD+

    Nā hiʻohiʻona API:

    Maʻemaʻe kiʻekiʻe ≥99%

    NAD+ papa lāʻau lapaʻau

    Nā kūlana hana like GMP

    Kūpono ʻo NAD + API no ka hoʻohana ʻana i nā nutraceuticals, injectables, a me nā mea lapaʻau metabolic holomua.

  • ʻO Cagrilintide

    ʻO Cagrilintide

    ʻO Cagrilintide kahi mea hana agonist amylin receptor agonist lōʻihi i hoʻomohala ʻia no ka mālama ʻana i ka momona a me nā maʻi metabolic pili i ke kaumaha. Ma ka hoʻohālikelike ʻana i ka amylin hormone maoli, kōkua ia i ka hoʻoponopono ʻana i ka ʻai, hoʻolohi i ka hoʻohemo ʻana o ka ʻōpū, a hoʻonui i ka māʻona. Hoʻokumu ʻia kā mākou Cagrilintide API maʻemaʻe kiʻekiʻe ma o ka synthesis kemika a hoʻokō i nā kūlana lāʻau lapaʻau, kūpono ia no ka hoʻohana ʻana i nā hoʻolālā hoʻokele paona kiʻekiʻe.

  • Tesamorelin

    Tesamorelin

    Hoʻohana ʻo Tesamorelin API i ka ʻenehana holomua solid phase peptide synthesis (SPPS) a loaʻa iā ia nā hiʻohiʻona aʻe:

    Maʻemaʻe ≥99% (HPLC)
    ʻAʻohe endotoxin, nā metala kaumaha, nā mea hoʻoheheʻe koena i hoʻāʻo ʻia
    ʻO ke kaʻina amino acid a me ke ʻano i hōʻoia ʻia e LC-MS/NMR
    Hāʻawi i ka hana maʻamau i nā grama i nā kilokani

  • N-Acetylneuraminic Acid(Neu5Ac Sialic Acid)

    N-Acetylneuraminic Acid(Neu5Ac Sialic Acid)

    ʻO ka N-Acetylneuraminic Acid (Neu5Ac), i ʻike mau ʻia ʻo ialic acid, he monosaccharide kūlohelohe i komo i loko o nā hana koʻikoʻi a me nā hana pale. He kuleana koʻikoʻi ia i ka hōʻailona cell, pale pathogen, a me ka ulu ʻana o ka lolo.

  • Ergothioneine

    Ergothioneine

    ʻO Ergothioneine kahi antioxidant i loaʻa maoli i ka amino acid, i aʻo ʻia no kāna mau cytoprotective ikaika a me nā waiwai anti-kahiko. Hoʻopili ʻia ia e nā haʻiki a me ka bacteria a hōʻiliʻili i loko o nā ʻiʻo i ʻike ʻia i ke koʻikoʻi oxidative.

1234Aʻe >>> ʻAoʻao 1 / 4